Table 1.
Patient demographic details
| Patient | Age | Sex | Location | Pre-op VA | Post-op VA* | Tumor basal diameter pre and post | Tumour thickness pre and post | Treatment | Treatment response | Follow up (months) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 39 | F | Superior | 20/40, N36 | 20/25, N6 | 10 (5) | 4 (2) | TTT (2) | flat scar | 10 |
| 2 | 62 | F | Inferior | 20/100, N18 | NA | 7.8 | 3.8 | NO | - | |
| 3 | 38 | M | Inferior | 20/30, N10 | 20/30, N8 | 7 (5) | 3 (2) | TTT (2) | flat but no fibrosis | 6 |
| 4 | 41 | F | Temporal | 20/20, N6 | NA | 10 | 3 | NO | - | |
| 5 | 57 | F | Superior | 20/25, N6 | NA | 3 | 1.2 | NO | - | |
| 6 | 42 | M | Macula | 20/500, N36 | 20/600, N36 | 10 (5.7) | 5 (1.3) | TTT (3) | flat scar with fibrosis | 24 |
| 7 | 30 | M | Nasal, Mac SRF | 20/200, N24 | 20/125, N24 | 8 (8) | 4 (3.5) | TTT (2) | incomplete scar | 4 |
| 8 | 57 | M | Superior | 20/20, N6 | NA | 5 | 2.8 | NO | - | |
| 9 | 46 | M | Macula | 20/200, N24 | 20/100, N24 | NA | NA | PDT (2)+ ACCENTRIX | incomplete scar | 15 |
| 10 | 43 | F | Superior, Mac SRF | 20/50, N36 | 20/25, N6 | 8.8 (7) | 4 (2) | TTT (3) | flat | 4 |
| 11 | 37 | F | Macula | 20/600, N36 | 20/125, N18 | 9 (2) | 3 (1.6) | TTT (2) | flat scar with fibrosis | 4 |
| 12 | 41 | M | Macula | 20/40, N18 | 20/200, N36 | 10 (10) | 4 (4) | PDT (2) | incomplete scar | 6 |
| 13 | 45 | M | Macula | 20/320, N24 | 20/125, N12 | 6 (2) | 2.5(NA) | TTT (3) | flat scar with fibrosis | 6 |
| 14 | 54 | M | Macula | 20/30, N6 | 20/50, N24 | 5.6 (3.4) | 3 | PDT (2) | persistent srf | 5 |
| 15 | 34 | M | superior | 20/25, N6 | 20/20, N6 | 7 (4) | 2 | PDT (1) | flat | 11 |
| 16 | 31 | F | Temporal | 20/25, N6 | 20/20, N6 | 6 (4.5) | 2 | PDT (2) | flat | 4 |
*Post op vision of 12 treated eyes are available